1Acheson DW,Luccioli S.Microbial-gut interactions in health and disease.Mucosal immune responses.Best Pract Res Clin Gastroenterol,2004,18:387-404.
2Ibrahim HR,Sugimoto Y,Aoki T.Ovotransferrin antimicrobial peptide (OTAP-92) kills bacteria through a membrane damage mechanism.Biochim Biophys Acta,2000,1523(2-3):196-205.
3Harder J,J Bartels E Christophers,JM Schroder.Isolation and characterization of human beta-defensin-3,a novel human inducible peptide antibiotic.J Biol Chem,2001,276:5707-5713.
4Joly S,Maze C,McCray PB,et al.Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms.J Clin Microbiol,2004,42:1024-1029.
5Joly S,Organ CC,Johnson GK,et al.Correlation between beta-defensin:expression and induction profiles in gingival keratinocytes.Mol Immunol,2005,42(9):1073-1084.
7Komatsuzawa H,Ouhara K,Kawai T,et al.Susceptibility of Periodontopathogenic and Cariogenic Bacteria to Defensins and Potential Therapeutic Use of Defensins in Oral Diseases.Current Pharmaceutical Design,2007,30(13):3084-3095(12).
9Maisetta G,Batoni G,Esin S,et al.Susceptibility of Streptococcus mutans and Actinobacillus actinomycetemcomitans to bactericidal activity of human ?-defensin 3 in biological fluids.Antimicrob.Agents Chemother,2005,49:1245-1248.
4Hancock Robert E W. Cationic peptides: effectors in innate immunityand novel antimicrobials. Lancet Infect Dis, 2001,11( 1 ): 156 ～ 164.
5Periathamby A R, Andrew R D. Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol Lett, 2002, 206: 9～ 18.
6Ganz T, Selsted M E, Szklarek D, Harwig S S, Daher K, Bainton D F, Lehrer R I. Defensins, Natural peptide antibiotics of human neutrophils. J Clin Invest, 1985,76(4): 1427 ～ 1435.
7Bensch K W, Raida M, Magert H J. hBD-1 :a novel beta-defensin from human plasma. FEBS Lett, 1995,368: 331.
8Harder J, Bartels J. Christophers E, Schroder J M. A peptide antibiotic from human skin. Nature, 1997,387: 861.
9Harder J, Bartels J. Christophers E, Schroder J M. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem, 2001, 276(8): 5707～5713.
10Garcia J R, Krause A, Schulz S, Rodriguez-Jimenez F J, Kluver E, Adermann K, Forssmann U, Frimpong-Boateng A Bals R, Forssmann WG. Human β-defensin-4: a novel inducible peptide with a special salt sensitive spectrum of antimicrobial activity. FASEB J, 2001,15:1819 ～ 1821.
2VERMA C, SEEBAH S, LOW S M, et al. Defensins: antimicrobial peptides for therapeutic development [ J]. Biotechnol J, 2007, 2 (11) : 1353 -1359.
3YANG D, BIRAGYN A, KWAK L W, et al. Mammalian defensins in immunity: more than just mierobieidal [ J]. Trends Immunol, 2002, 23(6) : 291 -296.
4SELSTED M E, OUELLETTE A J. Mammalian defensins in the an- timicrobial immune response [ J]. Nat Immunol, 2005, 6 (6) : 551 -557.
5BIRAGYN A, RUFFINI P A, LEIFER C A, et al. Toll -like re- ceptor 4 - dependent activation of dendritic cells by β - defensin 2 [J]. Science, 2002, 298(5595): 1025-1029.
6BRAMWELL V, SOMAVARAPU S, OUTSCHOORN I, et al. Ad- juvant action of melittin following intranasal immunisation with teta- nus and diphtheria toxoids [ J ]. J Drug Target, 2003, 11 (8/9/ 10) : 525 -530.
7AN L L, YANG Y H, MA X T, et al. LL -37 enhances adaptive antitumor immune response in a murine model when genetically fused with M-CSFR (J6 - 1) DNA vaccine [J]. Leuk Res, 2005, 29(5) : 535 -543.
8LILLARD J W, BOYAKA P N, CHERTOV O, et al. Mechanisms for induction of acquired host immunity by neutrophil peptide de- fensins [J]. PNAS, 1999, 96(2) : 651 -656.
9TANI K, MURPHY W J, CHERTOV O, et al. Defensins act as po- tent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens [ J]. Int lmmu- nol, 2000, 12(5): 691 -700.
